↓ Skip to main content

Phase II Study of Carboplatin and Paclitaxel in Advanced Thymoma and Thymic Carcinoma

Overview of attention for article published in Journal of Clinical Oncology, April 2011
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • Good Attention Score compared to outputs of the same age and source (69th percentile)

Mentioned by

patent
2 patents
guideline
3 clinical guideline sources

Readers on

mendeley
112 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Phase II Study of Carboplatin and Paclitaxel in Advanced Thymoma and Thymic Carcinoma
Published in
Journal of Clinical Oncology, April 2011
DOI 10.1200/jco.2010.32.9607
Pubmed ID
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 112 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Geographical breakdown
Country Count As %
Japan 3 3%
Switzerland 1 <1%
Unknown 108 96%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Researcher 24 21%
Other 19 17%
Student > Postgraduate 9 8%
Student > Doctoral Student 8 7%
Student > Bachelor 8 7%
Other 20 18%
Unknown 24 21%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 74 66%
Pharmacology, Toxicology and Pharmaceutical Science 4 4%
Agricultural and Biological Sciences 4 4%
Immunology and Microbiology 1 <1%
Economics, Econometrics and Finance 1 <1%
Other 2 2%
Unknown 26 23%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 June 2025.
All research outputs
#3,289,801
of 29,400,575 outputs
Outputs from Journal of Clinical Oncology
#8,640
of 27,327 outputs
Outputs of similar age
#13,989
of 132,140 outputs
Outputs of similar age from Journal of Clinical Oncology
#80
of 280 outputs
Altmetric has tracked 29,400,575 research outputs across all sources so far. Compared to these this one has done well and is in the 88th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 27,327 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.2. This one has gotten more attention than average, scoring higher than 66% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 132,140 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 280 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 69% of its contemporaries.